OpenAI has asked third-party contractors to upload real examples of work they produced in past or current jobs to help train ...
January 08, 2026 - PRESSADVANTAGE - Silverback Webinar has announced continued development and refinement of its ...
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Through vivid fighter pilot stories and actionable insights, the author guides readers through the three phases from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results